China Risun Group (SEHK:1907), Why Is Its Latest Update Drawing Attention?

China Risun Group (SEHK:1907) issued new earnings guidance for the first half of 2026, saying net profit is expected to be at least 335% above the prior year period, driven mainly by wider refined chemical price spreads.

See our latest analysis for China Risun Group.

At a share price of HK$1.985, China Risun Group has seen short term momentum pick up, with a 7 day share price return of 7.88%. However, the 1 year total shareholder return is down 17.84%, which points to weaker longer term performance despite the stronger earnings guidance.

If this kind of earnings driven move has your attention, it can be useful to look at other materials related names through a focused screener such as 28 best rare earth metal stocks

After a sharp upgrade to earnings guidance and a quick bounce in the share price, the real issue for China Risun Group now is simple. Does the current valuation still leave enough upside to justify the risks?

Preferred P/E of 125.4x: Is it justified?

China Risun Group is currently trading on a P/E of 125.4x, which is high relative to many Hong Kong stocks and to its own recent share price performance.

The P/E multiple compares the current share price to the company's earnings per share. For a cyclical materials business like China Risun Group, investors often watch this closely because earnings can move sharply with commodity spreads and one off factors.

In this case, the current P/E of 125.4x is described as expensive relative to several reference points. It is above the estimated fair P/E of 18.7x that the SWS fair ratio model suggests the market could move toward over time. It is also well above the Hong Kong Chemicals industry average of 10.6x and above a peer average of 9.1x. That is a wide gap, which implies the market price is rich compared with both sector norms and the level suggested by the fair ratio work.

Explore the SWS fair ratio for China Risun Group

Result: Price-to-earnings of 125.4x (OVERVALUED).

However, the China Risun Group story still carries risks, including its heavy exposure to cyclical coke and chemical spreads and its long term total return track record.

Find out about the key risks to this China Risun Group narrative.

Another view on China Risun Group's value

While the P/E of 125.4x looks expensive, the SWS DCF model tells a very different story. At a share price of HK$1.985, China Risun Group is trading at 85.4% below an estimated fair value of HK$13.61. That suggests a large gap between earnings based and cash flow based views. Which one do you trust more?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out China Risun Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 269 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With such mixed signals around China Risun Group, it makes sense to look at the full data set and decide where you stand. To see how the positives stack up against the concerns, review the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond China Risun Group?

Do not stop with China Risun Group if you want a stronger watchlist. Use targeted stock lists to quickly find fresh ideas that match your style.

• Target potential mispricings by reviewing companies that show strong fundamentals relative to their valuations through the 269 high quality undervalued stocks.
• Build a steadier income stream by checking out companies with resilient payout profiles in the 424 dividend fortresses.
• Focus on staying power by scanning companies that rate well on financial strength using the 295 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com